Arlington Partners’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$220K Hold
7,698
0.4% 56
2026
Q1
$242K Buy
+7,698
New +$243K 0.48% 19
2025
Q4
Sell
-200,101
Closed -$5.05M 46
2025
Q3
$5.05M Buy
200,101
+131,826
+193% +$3.21M 1.75% 22
2025
Q2
$1.64M Buy
+68,275
New +$1.58M 0.6% 63

Other funds holding RTO

Arlington Partners's RTO Position: Q2 2026 in Review

Arlington Partners held its Rentokil (RTO) position steady in Q2 2026 at 7,698 shares worth $220K. The position accounts for 0.4% of the portfolio, ranked #56.

Arlington Partners first reported a position in RTO in Q2 2025 and has held it in 4 quarters since. The position peaked at $5.05M in Q3 2025. 23 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Arlington Partners held 7,698 shares of Rentokil worth $220K as of Q2 2026.
  • Arlington Partners left its Rentokil share count unchanged in Q2 2026.
  • Rentokil made up 0.4% of Arlington Partners's portfolio in Q2 2026, its #56 holding.
  • Arlington Partners first reported a position in Rentokil in Q2 2025 and has held it in 4 quarters since.
  • Arlington Partners's Rentokil position peaked at $5.05M in Q3 2025.
  • 23 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Arlington Partners's 13F filing for Q2 2026, filed 7 Jul 2026.